Stay informed with the latest litigation news. Explore now

IP Verse

Mitsubishi Tanabe Pharma Corporation V. Lupin Limited - 1:25-cv-00828

Explore the details of the Mitsubishi Tanabe Pharma Corporation V. Lupin Limited case under case number 1:25-cv-00828 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-00828
Filing Date
Jul 3, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Lupin Pharmaceuticals, Inc. -
Mitsubishi Tanabe Pharma Corporation -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US12285409B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 7, 2025Summons Issued as to Lupin Limited on 7/7/2025; Lupin Pharmaceuticals, Inc. on 7/7/2025. (Attachments: # 1 Summons Issued)(mpb) (Entered: 07/07/2025)PACER Document
Jul 3, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mitsubishi Chemical Group Corporation for Mitsubishi Tanabe Pharma Corporation filed by Mitsubishi Tanabe Pharma Corporation. (mpb) (Entered: 07/07/2025)PACER Document
Jul 3, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,285,409 B2. (mpb) (Entered: 07/07/2025)PACER Document
Jul 3, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 21, 2025. Date of Expiration of Patent: 11/1/2039.Thirty Month Stay Deadline: 11/21/2027. (mpb) (Entered: 07/07/2025)PACER Document
Jul 3, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 07/07/2025)PACER Document
Jul 3, 2025COMPLAINT for Patent Infringement filed against Lupin Limited, Lupin Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4725949.) - filed by Mitsubishi Tanabe Pharma Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 07/07/2025)PACER Document